Zydus
Manufacturing · India · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Zydus Corporate Park Scheme No. 63 Khora...Phone Number
+91 2717666555Website
www.zyduslife.comRevenue
$2.6 BillionStock Symbol
ZYDUSLIFEIndustry
About Zydus
Zydus Org Chart
President Corporate Matters
President
President (Special Projects)
President
President
Group President, Human Resources & Corporate ...
President
Is Zydus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Zydus
Earning: See what the market has to say on Zydus recently announced quarterly report
Check out if Zydus is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Zydus launches new products
Click to see if Zydus had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Zydus has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Zydus has new funding data
Zydus, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Zydus as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Zydus is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zydus is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zydus.
Zydus Tech Stack
A closer look at the technologies used by Zydus
Most Recent Scoops
Zydus News & Media
Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
LONDON and SOLANA BEACH, Calif. and AHMEDABAD, India, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (Nasdaq: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases and Sentynl Therapeutics, Inc. (“Sentynl”), a U.S.-based biopharmaceutical company and wholly-owned subsidiary of Zydus Lifesciences Limited (“Zydus”), today announced that they have entered into an option and license agreement for the U.S. commercial and global manufacturinZydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA
EPICS-III trial Phase 3 results demonstrated significant biochemical response; data to be presented as a late-breaking presentation at EASL Congress 2026. US FDA granted Priority Review and assigned PDUFA target action date of November 27, 2026. In the EPICS-III trial Phase 3 results,...Assertio: $166.4 Million Acquisition By Zydus Worldwide DMCC Announced - Pulse 2.0
Assertio Holdings announced that it has entered into a definitive agreement to be acquired by Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Limited, in an all-cash transaction valued at approximately $166.4 million.Sentynl Therapeutics Enters into Agreement with PRG S&T to License Molecule for Hutchinson-Gilford Progeria Syndrome
Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease products AHMEDABAD, India and SOLANA BEACH, Calif., March 16, 2026 /PRNewswire/ -- Sentynl Therapeutics Inc. ("Sentynl"), a...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zydus
Zydus is a global pharmaceutical company headquartered in Ahmedabad, India. Founded in 1952, the company operates manufacturing sites and research facilities across multiple states in India as well as in the United States and Brazil. Zydus specializes in developing, manufacturing, and distributing pharmaceutical products with a significant global f... Read More